MARKET

NRXP

NRXP

Nrx Pharmaceuticals Inc
NASDAQ
2.980
-0.015
-0.50%
Opening 14:18 09/28 EDT
OPEN
2.950
PREV CLOSE
2.995
HIGH
3.010
LOW
2.910
VOLUME
494.96K
TURNOVER
--
52 WEEK HIGH
5.06
52 WEEK LOW
1.620
MARKET CAP
129.03M
P/E (TTM)
-4.0518
1D
5D
1M
3M
1Y
5Y
1D
Ono Pharmaceutical Co. (OPHLF) Soars 13.9%: Is Further Upside Left in the Stock?
NASDAQ · 4d ago
NRX Pharmaceuticals (NRXP) Receives a Rating Update from a Top Analyst
TipRanks · 6d ago
Weekly Report: what happened at NRXP last week (0914-0918)?
Weekly Report · 09/21 09:51
NRX Pharmaceuticals Gains FDA Boost for Ketamine Review
TipRanks · 09/16 10:45
NRx Pharmaceuticals Reports FDA Reclassifies Ketamine Amendment As Minor
NASDAQ · 09/16 05:32
NRx Pharmaceuticals says FDA reclassifies ANDA amendment to ‘minor’
TipRanks · 09/15 19:15
FDA Reclassifies NRx Pharmaceuticals' Ketamine ANDA Amendment To Minor, Setting New Goal Date For November 10, 2026
Benzinga · 09/15 19:12
NRx Pharmaceuticals (Nasdaq: NRXP) Reports Update from the FDA Revising Previous Major Amendment to a Minor Amendment for Preservative-free Ketamine
Barchart · 09/15 14:11
More
About NRXP
NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing therapeutics based on its N-methyl-D-aspartate (NMDA) platform for the treatment of central nervous system disorders, specifically suicidal depression, chronic pain, and PTSD. It is developing NRX-100 (preservative-free intravenous ketamine) and NRX-101, (oral D-cycloserine/lurasidone). NRX-100 has been awarded Fast Track Designation for the treatment of Suicidal Ideation in Depression, including Bipolar Depression. NRX-101 has been awarded Breakthrough Therapy Designation for the treatment of suicidal bipolar depression. NRx has filed an Abbreviated New Drug Application (ANDA) and initiated a New Drug Application filing for NRX-100 (IV ketamine) with an application for the Commissioner’s National Priority Voucher Program for the treatment of suicidal depression. Its subsidiary, HOPE Therapeutics, Inc., is a healthcare delivery company that is building a network of interventional psychiatry clinics.

Webull offers NRX Pharmaceuticals Inc stock information, including NASDAQ: NRXP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NRXP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NRXP stock methods without spending real money on the virtual paper trading platform.